4//SEC Filing
Reardon Andrew 4
Accession 0002001011-25-000037
CIK 0000886163other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 8:06 PM ET
Size
6.3 KB
Accession
0002001011-25-000037
Insider Transaction Report
Form 4
Reardon Andrew
CLO & Secretary
Transactions
- Sale
Common Stock
2025-05-15$104.00/sh−1,000$104,000→ 32,903 total - Tax Payment
Common Stock
2024-08-10$100.16/sh−897$89,839→ 21,637 total
Footnotes (2)
- [F1]Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.
- [F2]The total includes 17 shares acquired on December 31, 2024, through the Issuer's Employee Stock Purchase Plan.
Documents
Issuer
LIGAND PHARMACEUTICALS INC
CIK 0000886163
Entity typeother
Related Parties
1- filerCIK 0001950232
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 8:06 PM ET
- Size
- 6.3 KB